MEDTAP International

MEDTAP International was a premier health economics and outcomes research (HEOR) and clinical research organization that provided specialized consulting services to the pharmaceutical and biotechnology industries. The company focused on demonstrating the value of medical products through economic modeling, patient-reported outcomes (PRO) development, and epidemiological studies. MEDTAP was widely regarded for its scientific rigor and its ability to bridge the gap between clinical data and market access requirements. Its expertise supported global product launches by providing the evidence needed for reimbursement and health policy decisions. In 2004, the company was acquired by United BioSource Corporation (UBC), where its capabilities were integrated into UBC's broader evidence-based medicine platform.